Another Look at Emergent Biosolutions Let s review the charts and indicators.
Apr 05, 2021 | 09:56 AM EDT
We checked out the charts of Emergent Biosolutions on March 4 and concluded that Despite the positive fundamental story EBS looks like it will retest the December/January lows. A break of the support around $80 will likely precipitate further declines. Sell any remaining longs. In this daily bar chart of EBS, below, we can see that prices sank into early March and then quietly drifted higher until this past Thursday when prices fell sharply and closed weak near the low of the day. The slope of the 50-day moving average line turned bearish during the past month and the On-Balance-Volume (OBV) line was weak and the Moving Average Convergence Divergence (MACD) oscillator has been in negative territory below the zero line all month.
Jim Cramer: Economy Gets Booster Shot Without the Side Effects Amid the vaccine rollout, we have low rates, money coming from the government to families, and a Fed committed to creating jobs. Here s what it all means for investors.
Apr 05, 2021 | 02:56 PM EDT What do you do when you have growth with no inflation coupled with an astonishing four million vaccines given in one day a Saturday? You pretty much buy everythingAnd that s just what people didFriday we had one of the greatest job numbers for the stock market that you could possibly haveWe got a gigantic number of jobs created 916,000 ab.
DGAP-PVR: Vonovia SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Acquisition/disposal of instruments
Other reason:
Legal entity: The Goldman Sachs Group, Inc.
City of registered office, country: Wilmington, DE, United States of America (USA)
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
Goldman Sachs & Co. LLC
29 March 2021
(total of 7.a.)
(total of 7.b.1 + 7.b.2)
New
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN
Type of instrument
Type of instrument
8. Information in relation to the person subject to the notification obligation
Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).